CEL-SCI (AMEX:CVM) reported quarterly losses of $(0.23) per share. This is a 8 percent increase over losses of $(0.25) per share from the same period last year.
Intersect ENT Insights: Return On Capital Employed
In Q1, Intersect ENT (NASDAQ:XENT) posted sales of $24.33 million. Earnings were up 7.66%, but Intersect ENT still reported an overall loss of $18.57 million. Intersect ENT collected $28.23 million in revenue during Q4, but reported earnings showed a $17.25 million loss.
